Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at BOSTON SCIENTIFIC CORP as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. BOSTON SCIENTIFIC CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. BOSTON SCIENTIFIC CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Michael F. Mahoney
Chairman of the Board, President and Chief Executive Officer
Total Cash $4,644,150 Equity $13,597,737 Other $190,181 Total Compensation $18,432,068
Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiology
Total Cash $1,810,217 Equity $3,589,794 Other $27,372 Total Compensation $5,427,383
Daniel J. Brennan
Executive Vice President and Chief Financial Officer
Total Cash $2,125,466 Equity $3,589,794 Other $23,677 Total Compensation $5,738,937
Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
Total Cash $1,387,068 Equity $2,284,421 Other $51,498 Total Compensation $3,722,987
Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
Total Cash $1,428,949 Equity $2,610,729 Other $62,299 Total Compensation $4,101,977
For its 2023 fiscal year, BOSTON SCIENTIFIC CORP, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Michael F. Mahoney CEO Pay $18,723,735 Median Employee Pay $54,147 CEO Pay Ratio 346:1
For its 2022 fiscal year, BOSTON SCIENTIFIC CORP, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Charles J. Dockendorff Total Cash $345,000
David J. Roux Total Cash $340,000
David S. Wichmann Total Cash $320,000
Donna A. James Total Cash $340,000
Edward J. Ludwig Total Cash $360,000
Ellen M. Zane Total Cash $320,000
John E. Sununu Total Cash $340,000
Nelda J. Connors Total Cash $323,023
Yoshiaki Fujimori Total Cash $320,000

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.